Private Capital Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $37K | Sell |
384
-317
| -45% | -$30.5K | 0.03% | 590 |
|
|
2022
Q1 | $66K | Buy |
701
+257
| +58% | +$24.2K | 0.02% | 543 |
|
|
2021
Q4 | $38K | Sell |
444
-159
| -26% | -$13.6K | 0.01% | 800 |
|
|
2021
Q3 | $58K | Buy |
603
+299
| +98% | +$28.8K | 0.01% | 617 |
|
|
2021
Q2 | $30K | Sell |
304
-59
| -16% | -$5.82K | 0.01% | 894 |
|
|
2021
Q1 | $35K | Sell |
363
-67
| -16% | -$6.46K | 0.01% | 790 |
|
|
2020
Q4 | $41K | Sell |
430
-119
| -22% | -$11.3K | 0.01% | 888 |
|
|
2020
Q3 | $53K | Buy |
549
+211
| +62% | +$20.4K | 0.01% | 682 |
|
|
2020
Q2 | $41K | Buy |
338
+24
| +8% | +$2.91K | 0.01% | 808 |
|
|
2020
Q1 | $27K | Buy |
314
+61
| +24% | +$5.25K | 0.01% | 894 |
|
|
2019
Q4 | $27K | Buy |
253
+55
| +28% | +$5.87K | 0.01% | 990 |
|
|
2019
Q3 | $18K | Buy |
198
+161
| +435% | +$14.6K | ﹤0.01% | 1237 |
|
|
2019
Q2 | $4K | Sell |
37
-166
| -82% | -$17.9K | ﹤0.01% | 1710 |
|
|
2019
Q1 | $18K | Buy |
+203
| New | +$18K | ﹤0.01% | 1255 |
|
|
2018
Q3 | – | Sell |
-37
| Closed | -$3K | – | 2265 |
|
|
2018
Q2 | $3K | Hold |
37
| – | – | ﹤0.01% | 1806 |
|
|
2018
Q1 | $3K | Sell |
37
-218
| -85% | -$17.7K | ﹤0.01% | 1759 |
|
|
2017
Q4 | $8 | Buy |
+255
| New | +$8 | ﹤0.01% | 1459 |
|